NEW YORK (GenomeWeb) – Molecular Profiles and Xceleron today announced a collaboration to help drug developers improve efficiency during the clinical development stage.

Xceleron's knowledge in using accelerator mass spectrometry technology in pharma applications will be added to Molecular Profiles' new Roadmap to Clinical Trials platform, launched earlier this month. The screening platform incorporates Molecular Profiles' existing formulation and analytical development modules to streamline the development of drugs.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.